New therapeutic approaches in sepsis: a critical review.
Eidelman
L A
LA
Department of Anesthesiology/Critical Care Medicine, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
Pizov
R
R
Sprung
C L
CL
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D004311:Double-Blind Method; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use*; D053590:Interleukin 1 Receptor Antagonist Protein; D016032:Randomized Controlled Trials as Topic; D018805:Sepsis / Q000628:therapy*; D012795:Sialoglycoproteins / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; C507763:IL1RN protein, human; D007136:Immunoglobulins; D053590:Interleukin 1 Receptor Antagonist Protein; D012795:Sialoglycoproteins; D014409:Tumor Necrosis Factor-alpha; C042866:antilipopolysaccharide antibodies